1. Why This Category Needs Extra Review
Weight-management products sit close to disease, drug-comparison and guaranteed-outcome claims. FDA does not permit dietary supplements to contain pharmaceutical ingredients or to be promoted to diagnose, treat, cure or prevent disease. FDA also warns that products marketed for weight loss are a recurring target for hidden drug ingredients.
For a private-label buyer, the consequence is practical: the formula, label, product page, advertising and creator content need one consistent claim standard.
2. Start With the Product Brief
| Buyer input | Why it matters |
|---|---|
| Target country and sales channel | Claims, warnings, ingredient status and platform rules vary by market and channel |
| Target consumer | Safety review and label language depend on who is expected to use the product |
| Ingredient form and amount per serving | Published evidence for one form or dose cannot automatically support another |
| Gummies per serving and daily servings | The total active load must physically fit while preserving acceptable texture and taste |
| Proposed claims | Claims determine the substantiation, disclaimer and review work needed before launch |
| Packaging and shelf-life target | Moisture, oxygen, light and heat can affect product quality and label-claim support |
3. Check Gummy Feasibility Before Promising a Label Amount
| Formulation issue | Buyer question |
|---|---|
| High gram-level serving | Can the proposed daily amount fit in a realistic gummy count? |
| Bitter or astringent botanical | Can flavor work be completed without hiding an impractical active load? |
| Fiber or swelling ingredient | Will it disrupt depositing, water activity or final texture? |
| Caffeine-containing material | Are source, amount, warnings and label presentation defined? |
| Heat- or oxygen-sensitive extract | What assay and stability plan will support the labeled amount through shelf life? |
| Multi-ingredient blend | Does evidence for one ingredient still match the finished combination and serving? |
4. Evidence Quality: What to Ask
Was the evidence from human trials or only laboratory and animal research?
Did the study use the same ingredient form and a relevant amount?
Was the study conducted on a finished combination or on one isolated ingredient?
Were the outcomes clinically meaningful and was the study long enough?
Are safety, medication interactions and target-user exclusions addressed?
Does the proposed label claim accurately reflect the evidence without promising weight loss?
5. Keep Drug Names and Drug Mechanisms Out of the Positioning
FDA’s structure/function guidance explains that naming a specific therapy, drug or drug action can associate a supplement claim with treatment of disease. Avoid positioning a gummy as a drug alternative, a drug mimic or a way to augment a prescription treatment. That rule applies beyond the physical label to webpages, marketplace listings, images, backend keywords and promotional scripts.
6. Build the Testing and Documentation Plan Around the Final Formula
Testing is not a single universal package. The plan should be tied to the confirmed formula, ingredients, serving, market and customer requirements. Depending on the project, buyers may request product specifications, formula or ingredient information, COA, MSDS, allergen and non-GMO statements, Supplement Facts support, stability work and third-party reports.
Aidacru can coordinate standard and customer-requested testing, including third-party testing. The selected laboratory, cost and additional lead time should be confirmed for the actual project rather than promised in a generic article.
7. Pre-Launch Checklist
Formula and serving are physically feasible in gummy format
Ingredient identity, source and specification are approved
Proposed claims are truthful, substantiated and do not imply disease treatment or drug equivalence
Supplement Facts, ingredient list, allergen information and warnings are reviewed
Sample flavor, texture, appearance and packaging are approved in writing
Finished-product specifications and release tests are defined
Stability work is appropriate to the product and intended shelf-life claim
Marketplace copy, advertising and creator briefs follow the same approved claim framework
Frequently Asked Questions
Can a gummy be marketed as a prescription-drug alternative?
No. A dietary supplement should not claim or imply that it acts like, replaces or augments a prescription therapy. Product naming, images, keywords and influencer copy all need review.
Do weight-management ingredients automatically work in gummy format?
No. The proposed serving might exceed the mass a practical gummy serving can hold, or the ingredient may create bitterness, instability or interaction concerns. Feasibility must be checked before the label amount is promised.
What evidence should a brand review?
Review human evidence for the ingredient, the studied form and amount, relevance to the finished product, safety, interactions and whether the proposed claim accurately reflects the evidence.
What documents can be planned for a custom project?
Depending on the confirmed formula and customer requirements, the document plan can include specifications, ingredient information, COA, allergen and non-GMO statements, Supplement Facts support, stability work and third-party testing. Scope, cost and timing should be agreed case by case.
Sources
NIH Office of Dietary Supplements: Dietary Supplements for Weight Loss
FDA: Structure/Function Claims Small Entity Compliance Guide
FDA: Label Claims for Conventional Foods and Dietary Supplements
Send the target market, ingredient forms and amounts, serving, claims, packaging and testing requirements. Aidacru can review manufacturing feasibility and identify which decisions must be resolved before sampling. See the private-label process.